Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis

Critical Care

Volumn 18, Issue 1, 2014, Pages

  Marino, Rossella ^a   Struck, Joachim ^b,c   Maisel, Alan S ^d   Magrini, Laura ^a   Bergmann, Andreas ^b,c   Somma, Salvatore D ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ADRENOMED AG   (Germany)

^c SPHINGOTEC GMBH   (Germany)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; HYPERTENSIVE FACTOR; VASOCONSTRICTOR AGENT;

AGED; APACHE; ARTICLE; CREATININE CLEARANCE; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; SURVIVOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VERY ELDERLY; ADULT; BLOOD; EMERGENCY HEALTH SERVICE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

ADRENOMEDULLIN; ADULT; AGED; APACHE; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SEPSIS; SEVERITY OF ILLNESS INDEX; VASOCONSTRICTOR AGENTS;

EID: 84896708403     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13731     Document Type: Article

References (24)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310. 10.1097/00003246-200107000-00002, 11445675.
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554. 10.1056/NEJMoa022139, 12700374.
3. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D, Sepsis Occurrence in Acutely Ill Patients Investigators Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-353. 10.1097/01.CCM.0000194725.48928.3A, 16424713, Sepsis Occurrence in Acutely Ill Patients Investigators.
4. Vincent JL. Sepsis definitions. Lancet Infect Dis 2002, 2:135. 10.1016/S1473-3099(02)00232-3, 11944181.
5. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41(2):580-637. 10.1097/CCM.0b013e31827e83af, 23353941, Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup.
6. Magrini L, Travaglino F, Marino R, Ferri E, De Berardinis B, Cardelli P, Salerno G, Di Somma S. Procalcitonin variations after Emergency Department admission are highly predictive of hospital mortality in patients with acute infectious diseases. Eur Rev Med Pharmacol Sci 2013, 17:133-142.
7. Travaglino F, De Berardinis B, Magrini L, Bongiovanni C, Candelli M, Silveri NG, Legramante J, Galante A, Salerno G, Cardelli P, Di Somma S. Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score. BMC Infect Dis 2012, 12:184. 10.1186/1471-2334-12-184, 3447640, 22874067.
8. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993, 192:553-560. 10.1006/bbrc.1993.1451, 8387282.
9. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, Marumo F. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 1996, 81:1449-1453.
10. Beltowski J, Jamroz A. Adrenomedullin-what do we know 10 years since its discovery?. Pol J Pharmacol 2004, 56:5-27.
11. Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000, 21:138-167.
12. Wong LY, Cheung BM, Li YY, Tang F. Adrenomedullin is both proinflammatory and antiinflammatory: its effects on gene expression and secretion of cytokines and macrophage migration inhibitory factor in NR8383 macrophage cell line. Endocrinology 2005, 146:1321-1327. 10.1210/en.2004-1080, 15576460.
13. Koo DJ, Zhou M, Chaudry IH, Wang P. The role of adrenomedullin in producing differential hemodynamic responses during sepsis. J Surg Res 2001, 95:207-218. 10.1006/jsre.2000.6013, 11162047.
14. Wang P, Ba ZF, Cioffi WG, Bland KI, Chaudry IH. The pivotal role of adrenomedullin in producing hyperdynamic circulation during the early stage of sepsis. Arch Surg 1998, 133:1298-1304. 10.1001/archsurg.133.12.1298, 9865646.
15. Ueda S, Nishio K, Minamino N, Kubo A, Akai Y, Kangawa K, Matsuo H, Fujimura Y, Yoshioka A, Masui K, Doi N, Murao Y, Miyamoto S. Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am J Respir Crit Care Med 1999, 160(1):132-136. 10.1164/ajrccm.160.1.9810006, 10390390.
16. Ehlenz K, Koch B, Preuss P, Simon B, Koop I, Lang RE. High levels of circulating adrenomedullin in severe illness: correlation with C-reactive protein and evidence against the adrenal medulla as site of origin. Exp Clin Endocrinol Diabetes 1997, 105:156-162. 10.1055/s-0029-1211745, 9228512.
17. Nishio K, Akai Y, Murao Y, Doi N, Ueda S, Tabuse H, Miyamoto S, Dohi K, Minamino N, Shoji H, Kitamura K, Kangawa K, Matsuo H. Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Crit Care Med 1997, 25(6):953-957. 10.1097/00003246-199706000-00010, 9201046.
18. Di Somma S, Magrini L, Travaglino F, Lalle I, Fiotti N, Cervellin G, Avanzi GC, Lupia E, Maisel A, Hein F, Wagner F, Lippi G. Opinion paper on innovative approach of biomarkers for infectious diseases and sepsis management in the emergency department. Clin Chem Lab Med 2013, 51(6):1167-1175.
19. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, International Surviving Sepsis Campaign Guidelines Committee Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36(1):296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437, International Surviving Sepsis Campaign Guidelines Committee.
20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
21. Lewis LK, Smith MW, Yandle TG, Richards AM, Nicholls MG. Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage. Clin Chem 1998, 44:571-577.
22. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 1823-1829, 2005:51.
23. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Muller B. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 2005, 9:R816-R824. 10.1186/cc3885, 1414007, 16356231.
24. Struck J, Tao C, Morgenthaler NG, Bergmann A. Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients. Peptides 2004, 25:1369-1372. 10.1016/j.peptides.2004.06.019, 15350706.